4-Sep-2026
Business Wire (Thu, 6-Aug 4:21 PM ET)
CareTrust REIT Announces Second Quarter 2026 Operating Results; Increases 2026 Guidance
Business Wire (Thu, 6-Aug 4:20 PM ET)
CareTrust REIT Sets Second Quarter Earnings Call for Friday, August 7, 2026
Business Wire (Thu, 23-Jul 4:06 PM ET)
CareTrust REIT Announces Quarterly Dividend of $0.39 per Share
Business Wire (Tue, 16-Jun 4:05 PM ET)
Market Chameleon (Tue, 19-May 7:33 AM ET)
CareTrust REIT Upsizes Stock Offering to $509.4 Million—What’s Behind the Forward Sale Strategy?
Market Chameleon (Tue, 19-May 3:54 AM ET)
CareTrust REIT Inc is a self-administered, publicly traded REIT engaged in the ownership, acquisition, financing, development, and leasing of skilled nursing, seniors housing, and other healthcare-related properties. The company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators under triple-net lease arrangements, in which the tenant is solely responsible for property-related costs. The company operates in Domestic and Foreign markets, with the majority of revenue coming from Domestic operations.
Caretrust REIT trades on the NYSE stock market under the symbol CTRE.
As of September 4, 2026, CTRE stock price declined to $39.01 with 964,744 million shares trading.
CTRE has a beta of 0.33, meaning it tends to be less sensitive to market movements. CTRE has a correlation of 0.02 to the broad based SPY ETF.
CTRE has a market cap of $9.22 billion. This is considered a Mid Cap stock.
Last quarter Caretrust REIT reported $161 million in Revenue and $.51 earnings per share. This beat revenue expectation by $6 million and met earnings estimates .
In the last 3 years, CTRE traded as high as $43.62 and as low as $19.67.
The top ETF exchange traded funds that CTRE belongs to (by Net Assets): VNQ, IJH, VTI, VB, VBK.
CTRE has underperformed the market in the last year with a price return of +18.7% while the SPY ETF gained +19.8%. However, in the short term, CTRE had mixed performance relative to the market. It has outperformed in the last 3 months, returning +5.2% vs +2.0% return in SPY. But in the last 2 weeks, CTRE shares have been beat by the market, returning -1.4% compared to an SPY return of +0.6%.
CTRE support price is $39.03 and resistance is $40.19 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CTRE shares will trade within this expected range on the day.